Nurix Therapeutics, Inc. · NASDAQ:NRIX
Deep Track Capital, LP reported a 5.44% stake in Nurix Therapeutics, Inc. (Schedule 13G)
Event Feb 7, 2025 · Filed Feb 14, 2025
Deep Track Capital, LP reported a 5.44% stake in Nurix Therapeutics, Inc., 4,125,000 shares, as a passive investor on Feb 7, 2025. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 5.44%
- Shares
- 4,125,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 5.44% | 4,125,000 |
| Deep Track Biotechnology Master Fund, Ltd. | 5.44% | 4,125,000 |
| David Kroin | 5.44% | 4,125,000 |
Source
Related
- Nurix Therapeutics, Inc.
- Deep Track Capital, LP
- Nurix Therapeutics, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2025
- Schedule 13G/A · Deep Track Capital, LP · Feb 14, 2025
- Form 4 · Hansen Gwenn · Oct 15, 2026
- Form 4 · Gregory Julia P · Oct 14, 2026
- Form 4 · Ring Christine · Oct 2, 2026
- Schedule 13G · Perceptive Advisors LLC · Sep 23, 2026
- Form 4 · Ring Christine · Sep 2, 2026